Zdrowie i gospodarka · 13/12/2004

FDA Requests Public Comment on Proposed Collection of Information for Fast Track Drug Development Programs

The Food and Drug Administration (FDA) is seeking public input on a proposed collection of information related to fast track designation for investigational new drugs and new drug approvals, as outlined in the FDA's guidance for industry on fast track drug development programs.